FOYA Program

Pharmaceutical manufacturing facilities need to evolve to satisfy growing demands, as breakthrough therapeutics approach commercialization. The pharmaceutical industry can enhance efficiency, flexibility, and product quality, by systematically...

Judges Name Four Category Winners Plus Two Honorable Mentions with Plans to Unveil Overall FOYA Winner at the 2024 ISPE Annual Meeting & Expo, 13 October, in Orlando, Florida, USA ISPE recently announced category winners for its 2024 Facility of the...

The 2024 Facility of the Year Awards (FOYA) submission finalists are announced at the 2024 ISPE Aseptic Conference, taking place in Vienna, Austria, and virtually.  ISPE is pleased to announce the 2024 Facility of the Year Awards (FOYA) submission...

ISPE President and CEO Thomas Hartman provides insights on how AI may impact the biotech industry in 2024. Thomas observes that the meteoric rise of AI took every industry by surprise in 2023. In 2024, he notes, “companies will have more time to take...

ISPE President and CEO Thomas Hartman calls attention to the importance of addressing drug shortages in 2024 in part three of an article, “Scrip Asks…What Does 2024 Hold for Biopharma?” The article features expert insights on manufacturing and supply...

Thomas Hartman, President and CEO of ISPE, has been featured in a recent podcast episode with Life Science Success. He and the host, Don Davis, discuss Hartman’s career journey and the impact ISPE is having on the industry. Hartman touches on...

Thomas Hartman, President and CEO of the International Society for Pharmaceutical Engineering, is among several key industry leaders featured in this article, discussing the advantages and challenges associated with integrating AI into drug...

The COVID-19 pandemic has prompted regulators and the industry to consider how best to prepare for future emergencies. In June 2023, the European Commission finalized deals with various European pharmaceutical companies to reserve manufacturing...